(AVUS) Avantis U.S. Equity - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US0250728856 • Large Blend
AVUS: Stocks, Futures, Forwards, Swaps
Avantis U.S. Equity ETF (NYSE ARCA: AVUS) offers exposure to a broad spectrum of U.S. companies, spanning various market sectors and industry groups. This diversification aims to capture the performance of the U.S. equity market while managing risk through a spread across different segments. The fund is not constrained by market capitalization, meaning it can invest in small-cap, mid-cap, and large-cap companies, allowing for a more comprehensive representation of the market.
Under normal market conditions, the fund allocates at least 80% of its assets to equity securities of U.S. companies. This threshold ensures a strong equity focus while providing flexibility to adjust the portfolio as market conditions evolve. Additionally, the fund may employ derivative instruments such as futures contracts, currency forwards, and swap agreements. These tools are typically used for hedging purposes, to manage risk, or to gain exposure to specific assets without directly holding them, rather than for speculative purposes.
With an AUM of $8.067 billion, AVUS is a sizeable ETF, indicating a high level of investor interest and liquidity. The fund is classified under the Large Blend ETF category, reflecting its focus on large-cap U.S. equities and its blend of growth and value investment styles. Its expense ratio of 0.15% makes it a cost-effective option for investors seeking broad U.S. equity exposure. This combination of diversification, flexibility, and cost efficiency makes AVUS a compelling choice for both individual and institutional investors seeking long-term equity returns.
Additional Sources for AVUS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AVUS ETF Overview
Market Cap in USD | 8,247m |
Category | Large Blend |
TER | 0.15% |
IPO / Inception | 2019-09-24 |
AVUS ETF Ratings
Growth 5y | 79.4% |
Fundamental | - |
Dividend | 63.3% |
Rel. Strength Industry | -2.6 |
Analysts | - |
Fair Price Momentum | 94.54 USD |
Fair Price DCF | - |
AVUS Dividends
Dividend Yield 12m | 1.28% |
Yield on Cost 5y | 2.45% |
Annual Growth 5y | 10.41% |
Payout Consistency | 100.0% |
AVUS Growth Ratios
Growth Correlation 3m | 4.5% |
Growth Correlation 12m | 94.1% |
Growth Correlation 5y | 84.3% |
CAGR 5y | 14.55% |
CAGR/Max DD 5y | 0.43 |
Sharpe Ratio 12m | 0.96 |
Alpha | -2.57 |
Beta | 1.00 |
Volatility | 11.65% |
Current Volume | 265.6k |
Average Volume 20d | 285.7k |
As of February 22, 2025, the stock is trading at USD 98.98 with a total of 265,574 shares traded.
Over the past week, the price has changed by -2.07%, over one month by -1.80%, over three months by -0.63% and over the past year by +19.04%.
Yes. Based on ValueRay Analyses, Avantis U.S. Equity (NYSE ARCA:AVUS) is currently (February 2025) a good stock to buy. It has a ValueRay Growth Rating of 79.36 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AVUS as of February 2025 is 94.54. This means that AVUS is currently overvalued and has a potential downside of -4.49%.
Avantis U.S. Equity has no consensus analysts rating.
According to ValueRays Forecast Model, AVUS Avantis U.S. Equity will be worth about 113.5 in February 2026. The stock is currently trading at 98.98. This means that the stock has a potential upside of +14.62%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 113.5 | 14.6% |